GLAND
NSEGland Pharma Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,479.40
9.90 (0.40%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹40.85K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
39.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,573.6+57.6%
52W High₹2,573.5-3.7%
Current Price
₹2,479.40
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,983.52
Upper Circuit₹2,975.28
Reference Price
₹2,479.40
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹2714.2
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹2622.2
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 47.48 (BUY) with 85.5% confidence
Volume divergence: Bearish (price up, volume down)
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
86%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
2385.31
EMA50
2223.7
EMA200
1981.41
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows6
Lower Highs4
Lower Lows3
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹2395.50
₹2196.00
₹2167.80
₹2131.00
₹2074.00
Volume Analysis
TrendSTABLE
Change-1.40%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹2454.61
3% Risk₹2405.02
5% Risk₹2355.43
7% Risk (Custom)
₹2305.84Technical Levels
1x ATR (Volatility)₹2395.26
2x ATR (Swing)₹2311.12
3x ATR (Trend)₹2226.98
Immediate Support₹2395.50
Moving Averages
EMA 9 (Short-term)₹2456.77
EMA 20 (Medium-term)₹2385.31
EMA 50 (Trend)₹2223.70
EMA 200 (Long-term)₹1981.41
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,384.1 Cr | ₹1,392 Cr | ₹1,505.6 Cr | ₹1,695.4 Cr |
| Net Profit | ₹204.7 Cr | ₹186.5 Cr | ₹215.5 Cr | ₹261.5 Cr |
| EPS | ₹12.42 | — | ₹13.08 | ₹15.87 |
| Operating Profit | ₹418.4 Cr | ₹386.9 Cr | ₹425.3 Cr | ₹473.7 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Gland Pharma Limited | ₹2,479.40 | +0.40% | 39.7 | ₹40.85K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 14 Aug 2025 | Dividend - Rs 18 Per Share | DIVIDEND |
| 16 Aug 2024 | Annual General Meeting/Dividend - Rs 20 Per Share | AGM |
| 06 Aug 2021 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for GLAND
View AllNEWS
positive
Business Standard - Markets 4d ago
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd is quoting at Rs 2510.4, up 1.92% on the day as on 12:49 IST on the NSE. The stock is up 32.94% in last one year as compared to a 4.13% jump in NIFTY and a 16.41% jump in the Nifty Pharma index.
AONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFGLANDPHARMABEESPVTBANIETFFinancial ServicesHealthcare
positive
Business Standard - Markets 17d ago
HDFC Securities analyst flags key support levels for Nifty; 2 stocks to buy
Gland Pharma has given a breakout from a bullish 'Inverted head and shoulder' pattern, and Viyash Scientific from bullish 'Cup and handle pattern', says Vinay Rajani of HDFC Securities.
GLANDHDFCGROWTHHDFCLIQUIDHDFCMID150HDFCNEXT50HDFCNIF100HDFCNIFBANHDFCNIFITHDFCNIFTYHDFCPSUBKHDFCPVTBANHDFCSML250PHARMABEESVIYASHFinancial ServicesHealthcare
positive
ET Markets - Stocks 29d ago
Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month
Despite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-week highs, gaining up to 35% over the past month amid strong investor buying.
AEGISLOGBSEBSE500IETFCONSUMERDIVIDENDGLANDHDFCBSE500HONASASJLOGISTICFast Moving Consumer GoodsFinancial Services